Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Thursday, March 28, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
admin
-
February 3, 2024
Latest Pharma-News
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases
admin
-
February 1, 2024
Latest Pharma-News
New £1.3m national research programme to evaluate coronavirus tests
admin
-
June 24, 2020
0
Latest Pharma-News
Novartis research shows technology talent increasingly drawn to pharma industry since COVID-19
admin
-
June 24, 2020
0
Latest Pharma-News
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
admin
-
June 24, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: Daily Roundup June 23, 2020
admin
-
June 24, 2020
0
Latest Pharma-News
IMBRUVICA® Seeks to Expand U.S. Label with Long-Term Data in Waldenström’s Macroglobulinemia
admin
-
June 24, 2020
0
Latest Pharma-News
Gilead Sciences Secures Exclusive Option to Acquire Pionyr Immunotherapeutics
admin
-
June 23, 2020
0
Latest Pharma-News
Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas
admin
-
June 23, 2020
0
Latest Pharma-News
EUROPEAN MEDICINES AGENCY VALIDATES APPLICATION FOR BAVENCIO® for UROTHELIAL CARCINOMA
admin
-
June 23, 2020
0
Latest Pharma-News
PFIZER ANNOUNCES START OF FOUR PHASE 3 CLINICAL TRIALS FOR INVESTIGATIONAL VACCINES
admin
-
June 23, 2020
0
Latest Pharma-News
Coronil: ICMR, AYUSH Ministry distance themselves from Patanjali’s cure for coronavirus
admin
-
June 23, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: Daily Roundup June 22, 2020
admin
-
June 23, 2020
0
Latest Pharma-News
FDA Accepts sBLA for BOTOX® (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
admin
-
June 23, 2020
0
1
...
100
101
102
...
144
Page 101 of 144
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024